ARTIVION, INC. (AORT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US2289031005
ARTIVION, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 441.33 m USD |
| Gross profit | 284.23 m USD |
| Operating income | 33.75 m USD |
| EBIT | 40.60 m USD |
| Net income | 9.77 m USD |
| Diluted EPS – continuing operations | 0.21 USD |
Full history since 1991, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ARTIVION, INC.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.
More stocks
- Chengdu Yunda Technology Co Ltd (300440.SZ)
- NAPCO SECURITY TECHNOLOGIES, INC (NSSC)
- Amoy Diagnostics Co Ltd (300685.SZ)
- Grupo KUO S.A.B. de C.V (KUOB.MX)
- Lampsa Hellenic Hotels SA (LAMPS.AT)
- Amphastar Pharmaceuticals, Inc. (AMPH)
- PT Jhonlin Agro Raya Tbk (JARR.JK)
- Lanxess (LXS.DE)
- Inwido AB (publ) (INWI.ST)
- CGN New Energy Holdings Co Ltd (1811.HK)
- Jiangsu Bide Science and Technology Co. Ltd. (605298.SS)
- MBB (MBB.DE)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.